Is 4163 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6
Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 4163 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 4163 (SAR78.2) is trading below our estimate of fair value (SAR115.78)
Significantly Below Fair Value: 4163 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 4163?
Key metric: As 4163 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for 4163. This is calculated by dividing 4163's market cap by their current
earnings.
What is 4163's PE Ratio?
PE Ratio
18.5x
Earnings
ر.س358.65m
Market Cap
ر.س6.65b
4163 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: 4163 is expensive based on its Price-To-Earnings Ratio (18.5x) compared to the Asian Consumer Retailing industry average (16.4x).
Price to Earnings Ratio vs Fair Ratio
What is 4163's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
4163 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
18.5x
Fair PE Ratio
24x
Price-To-Earnings vs Fair Ratio: 4163 is good value based on its Price-To-Earnings Ratio (18.5x) compared to the estimated Fair Price-To-Earnings Ratio (24x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst 4163 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
ر.س78.20
ر.س104.68
+33.9%
8.7%
ر.س115.00
ر.س90.90
n/a
6
Dec ’25
ر.س78.00
ر.س105.52
+35.3%
8.0%
ر.س115.00
ر.س90.90
n/a
6
Nov ’25
ر.س88.20
ر.س110.32
+25.1%
8.2%
ر.س125.00
ر.س99.70
n/a
6
Oct ’25
ر.س95.00
ر.س110.32
+16.1%
8.2%
ر.س125.00
ر.س99.71
n/a
6
Sep ’25
ر.س92.40
ر.س110.49
+19.6%
8.4%
ر.س126.00
ر.س99.71
n/a
6
Aug ’25
ر.س87.90
ر.س113.34
+28.9%
9.5%
ر.س130.00
ر.س99.71
n/a
6
Jul ’25
ر.س88.00
ر.س113.34
+28.8%
9.5%
ر.س130.00
ر.س99.71
n/a
6
Jun ’25
ر.س89.90
ر.س114.17
+27.0%
8.6%
ر.س130.00
ر.س99.71
n/a
6
May ’25
ر.س95.80
ر.س116.26
+21.4%
8.1%
ر.س130.00
ر.س101.00
n/a
5
Apr ’25
ر.س94.80
ر.س118.46
+25.0%
6.3%
ر.س130.00
ر.س107.00
n/a
5
Mar ’25
ر.س114.40
ر.س118.46
+3.5%
6.3%
ر.س130.00
ر.س107.00
n/a
5
Feb ’25
ر.س112.20
ر.س118.46
+5.6%
6.3%
ر.س130.00
ر.س107.00
n/a
5
Jan ’25
ر.س106.00
ر.س115.46
+8.9%
4.2%
ر.س120.30
ر.س107.00
n/a
5
Dec ’24
ر.س102.20
ر.س109.46
+7.1%
5.0%
ر.س115.00
ر.س100.30
ر.س78.00
5
Nov ’24
ر.س94.90
ر.س106.06
+11.8%
5.4%
ر.س115.00
ر.س100.00
ر.س88.20
5
Oct ’24
ر.س97.90
ر.س106.06
+8.3%
5.4%
ر.س115.00
ر.س100.00
ر.س95.00
5
Sep ’24
ر.س95.60
ر.س105.06
+9.9%
5.2%
ر.س115.00
ر.س100.00
ر.س92.40
5
Aug ’24
ر.س101.40
ر.س103.46
+2.0%
7.2%
ر.س115.00
ر.س92.00
ر.س87.90
5
Jul ’24
n/a
ر.س99.06
0%
15.4%
ر.س115.00
ر.س70.00
ر.س88.00
5
Jun ’24
ر.س90.00
ر.س93.33
+3.7%
17.7%
ر.س105.00
ر.س70.00
ر.س89.90
3
May ’24
ر.س77.80
ر.س62.00
-20.3%
12.9%
ر.س70.00
ر.س54.00
ر.س95.80
2
Dec ’23
ر.س72.50
ر.س67.00
-7.6%
25.4%
ر.س84.00
ر.س50.00
ر.س102.20
2
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2024/12/22 02:31
End of Day Share Price
2024/12/22 00:00
Earnings
2024/09/30
Annual Earnings
2023/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Al-Dawaa Medical Services Company is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.